Short answer
ANI PHARMACEUTICALS INC (ANIP) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 7.01 (Regulation FD Disclosure). Reg FD disclosure signed by CFO Stephen P. Carey on March 3, 2026, indicating material non-public information was selectively shared and is now being publicly disclosed.
ANI PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure signed by CFO Stephen P. Carey on March 3, 2026, indicating material non-public information was selectively shared and is now being publicly disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ANI PHARMACEUTICALS INC 8-K filings
Get the next ANIP 8-K as it lands
Follow ANIP for push alerts, or ask the research agent what this filing means.